Related topics

Heron Therapeutics: 2Q Earnings Snapshot

August 5, 2020 GMT

SAN DIEGO (AP) _ Heron Therapeutics Inc. (HRTX) on Wednesday reported a loss of $55.2 million in its second quarter.

On a per-share basis, the San Diego-based company said it had a loss of 61 cents.

The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 59 cents per share.

The pharmaceutical company posted revenue of $22.7 million in the period, surpassing Street forecasts. Four analysts surveyed by Zacks expected $16.4 million.

Heron Therapeutics expects full-year revenue in the range of $70 million to $80 million.


Heron Therapeutics shares have dropped 26% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $17.47, a rise of 6% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HRTX at https://www.zacks.com/ap/HRTX